Macrophage-assisted inflammation and pharmacological regulation of the cholinergic anti-inflammatory pathway

Current Medicinal Chemistry

Volumn 18, Issue 4, 2011, Pages 539-551

  Pohanka, M ^a   Snopkova, S ^b,c   Havlickova, K ^b,c   Bostik, P ^a   Sinkorova, Z ^a   Fusek, J ^a   Kuca, K ^a   Pikula, Jiri ^d  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^d UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Acetylcholine receptor; Acetylcholinesterase; Cell; Infection; Inflammation; Innate immunity; Parasympathetic nervous system; Tumour necrosis factor

Indexed keywords

4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; [2 (4 PYRIDIN 3 YLMETHYL)PIPERAZIN 1 YL]ETHANOL; ACETYLCHOLINESTERASE; ACETYLSALICYLIC ACID; ADALIMUMAB; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFLAMMATORY AGENT; ANTIRETROVIRUS AGENT; CERTOLIZUMAB PEGOL; COLEXCOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; EPIBATIDINE; ETANERCEPT; FLUDROCORTISONE; HYDROCORTISONE; IBUPROFEN; INFLIXIMAB; JAY 2 22 23; JAY 2 22 33; JWB 1 84 1; MUSCARINE; NAPROXEN; NEOSTIGMINE; NICOTINE; NICOTINIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; REACTIVE OXYGEN METABOLITE; ROFECOXIB; SEMAPIMOD; SPIRO[1 AZABICYCLO[2.2.2]OCTANE 3,2' THIAZOLIDINE] 2' ONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL THERAPY; ARTHRITIS; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CELL LOSS; CELLULAR IMMUNITY; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; CHOLINERGIC SYSTEM; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENTERITIS; ENZYME INHIBITION; EYE INFLAMMATION; HEART FAILURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; INTESTINE ULCER; INTOXICATION; LEUKOCYTE; LOW DRUG DOSE; MACROPHAGE; MACROPHAGE ACTIVATION; MYASTHENIA GRAVIS; NEUROMODULATION; NONHUMAN; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ACETYLCHOLINESTERASE; ADRENAL CORTEX HORMONES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOLINERGIC AGENTS; HIV INFECTIONS; HUMANS; INFLAMMATION; MACROPHAGES; REACTIVE OXYGEN SPECIES; RECEPTORS, NICOTINIC;

EID: 79851491493     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711794480140     Document Type: Article

References (129)

1. Majewski, W. D.; Silikowski, T.; Kaminski, M.; Ostrowski, M. Splenic and parasplenic abscess as a late complication of laparoscopic nissen fundoplication - case report and review of the literature. Ann. Acad. Med. Stetin., 2007, 53, 39-41.
2. Wallis, R. S. Infectious complications of tumor necrosis factor blockade. Curr. Opin. Infect. Dis., 2009, 22, 403-409.
3. Hardy, R.; Cooper, M. S. Bone loss in inflammatory disorders. J. Endocrinol., 2009, 201, 309-320.
4. Lu, Y. S.; Yeh, P. Y.; Chuang, S. E.; Gao, M.; Kuo, M. L.; Cheng, A. L. Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kappaB activation in the glucocorticoid receptor - rich human cervical carcinoma cell line SiHa. J. Endocrinol., 2006, 188, 311-319. (Pubitemid 43273819)
5. Green, G. A. Understanding NSAIDs: from aspirin to COX-2. Clin. Cornerstone, 2001, 3, 50-60.
6. Annane, D.; Bellissant, E.; Bollaert, P. E.; Briegel, J.; Confalonieri, M.; De Gaudio, R.; Keh, D.; Kupfer, D.; Oppert, M.; Meduri, G. U. Corticosteroids in the treatment of severe sepsis shock in adults: a systematic review. JAMA, 2009, 301, 2362-2375.
7. Barnes, P. J.; Adcock I. M. Glucocorticoid resistance in inflammatory diseases. Lancet, 2009, 373, 1905-1917.
8. Lefering, R.; Neugebauer E. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit. Care Med., 1995, 23, 1294-1303.
9. Aberdein, J.; Singer M. Clinical review: a systematic review of corticosteroid use in infections. Crit. Care, 2006, 10, 203.
10. Annane, D.; Sebille, V.; Charpentier, C.; Bollaert, P. E.; Francois, B.; Korach, J. M.; Capellier, G.; Cohen, Y.; Azoulay E.; Troche G.; Chaumet-Riffaut, P.; Bellissant, E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA, 2002, 288, 862-871.
11. Soberman, R. J.; Christmas, P. The organization and consequences of eicosanoid signaling. J. Clin. Invest., 2003, 111, 1107-1113. (Pubitemid 36519924)
12. Wallace, J. L.; Cirino, G. The development of gastrointestinalsparing nonsteroidal anti-inflammatory drugs. Trends Pharmacol. Sci., 1994, 15, 405-406. (Pubitemid 24360505)
13. Lynch, M. E.; Watson C. P. The pharmacotherapy of chronic pain: a review. Pain Res. Manag., 2006, 11, 11-38.
14. Ajmone-Cat, M. A.; Cacci E.; Minghetti L. Non steroidal antiinflammatory drugs and neurogenesis in the adult mammalian brain. Curr. Pharm. Des., 2008, 14, 1435-1442. (Pubitemid 351982551)
15. Scott, P. A.; Kingsley G. H.; Scott D. L. Non-steroidal antiinflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials. Eur. J. Heart Fail., 2008, 10, 1102-1107.
16. Levesque, L. E.; Brophy, J. M.; Zhang, B. The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study in elderly adults. Ann. Intern. Med., 2005, 142, 481-489.
17. Wilson, H. M.; Barker, R. N.; Erwig L. P. Macrophages: promising targets for the treatment of atherosclerosis. Curr. Vasc. Pharmacol., 2009, 7, 234-243.
18. Whitelaw, D. M. Observations on human monocyte kinetics after pulse labeling. Cell Tissue Kinet., 1972, 5, 311-317.
19. Fogg, D. K.; Sibon, C.; Miled, C.; Jung, S.; Aucouturier, P.; Littman, D. R.; Cumano, A.; Geissmann, F. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science, 2006, 311, 83-87. (Pubitemid 43063063)
20. Hemert, F. J.; Voermans, C.; Eck-Smit, B. L. F.; Bennink, R. J. Labeling monocytes for imaging chronic inflammation. Q. J. Nucl. Med. Mol. Imaging, 2009, 53, 78-88.
21. Abu El-Asrar, A. M.; Fatani, R. A.; Missotten, L.; Geboes, K. Expression of CD23/CD21 and CD40/CD40 ligand in vernal keratoconjunctivitis. Eye, 2001, 15, 217-224. (Pubitemid 32380997)
22. Perez-Arellano, J. L.; Losa-Garcia, J. E.; Orfao-Matos, A.; Gonzales, M.; de la Cruz, J. L.; Jimenez, A.; de Castro, S. Comparison of two techniques (flow cytometry and alkaline immunophosphatase) in the evaluation of alveolar macrophage immunophenotype. Diagn. Cytopathol., 1993, 9, 259-265. (Pubitemid 23155805)
23. Rickard, A. J.; Young, M. J. Costicosteroid receptors, macrophages and cardiovascular disease. J. Mol. Endocrinol., 2009, 42, 449-459.
24. Martinez, F. O.; Sica, A.; Mantovani, A.; Locati, M. Macrophage activation and polarization. Front. Biosci., 2008, 13, 453-461. (Pubitemid 351599757)
25. Ruster, C.; Wolf G. Role of chemokines and chemokine receptors in diabetic nephropathy. Front. Biosci., 2008, 13, 944-955. (Pubitemid 351594739)
26. Calafat, M.; Larocca, L.; Roca, V.; Hauk, V.; Pregi, N.; Nesse, A.; Leiros, C. P. Vasoactive intestinal peptide inhibits TNF-alphainduced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands. Arthitis Res. Ther., 2009, 11, R53.
27. Yamagishi, S. I.; Matsui, T. Anti-atherothrombogenic properties of PEDF. Curr. Mol. Med., 2010, 10, 284-291.
28. Lv, B.; Wang, H.; Tang, Y.; Fan, Z.; Xiao, X.; Chen, F. Highmobility group box 1 protein induced tissue factor expression in vascular endothelial cells via activation of NF-kappaB and EGR-1. Thromb. Haemost., 2009, 102, 352-359.
29. Voll, R. E.; Urbonaviciute, V.; Herrmann, M.; Kalden, J. R. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. Isr. Med. Assoc. J., 2008, 10, 26-28. (Pubitemid 351649458)
30. Goerdt, S.; Politz, O.; Schledzewski, K.; Birk, R.; Gratchev, A.; Guillot, P.; Hakiy, N.; Klemke, C. D.; Dippel, E.; Kodelja, V.; Orfanos, C. E. Alternative versus classical activation of macrophages. Pathobiology, 1999, 67, 222-226. (Pubitemid 30135909)
31. Duffield, J. S. The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. (Lond)., 2003, 104, 27-38. (Pubitemid 36249921)
32. Harding, C. V.; Ramachandra, L.; Wick, M. J. Interaction of bacteria with antigen presenting cells: influences on antigen presentation and antibacterial immunity. Curr. Opin. Immunol., 2003, 15, 112-119. (Pubitemid 35454201)
33. Afanasev, I. Superoxide and nitric oxide in senescence and aging. Front. Biosci., 2009, 14, 3899-3912.
34. Fialkow, L.; Wang, Y.; Downey, G. P. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Rad. Biol. Med., 2007, 42, 153-164. (Pubitemid 46001554)
35. Seib, K. L.; Wu, H. J.; Kidd, S. P.; Apicella, M. A.; Jennings, M. P.; McEwan, A. G. Defenses against oxidative stress in Neisseria gonorrhoeae: a system tailored for a challenging environment. Microbiol. Mol. Biol. Rev., 2006, 70, 344-361. (Pubitemid 43895031)
36. Greenberg, J. T.; Demple B. A global response induced in Escherichia coli by redox-cycling agents overlaps with that induced by peroxide stress. J. Bacteriol., 1989, 171, 3933-3939. (Pubitemid 19174169)
37. Pomposiello, P. J.; Bennik, M. H.; Demple, B. Genome-wide transcriptional profiling of the Escherichia coli responses to superoxide stress and sodium salicylate. J. Bacteriol., 2001, 183, 3890-3902. (Pubitemid 32565468)
38. Fernandez-Garcia, N.; Marti, M. C.; Jimenez, A.; Sevilla, F.; Olmos, E. Sub-cellular distribution of glutathione in an Arabidopsis mutant (vtc1) deficient in ascorbate. J. Plant. Physiol., 2009, 166, 2004-2012.
39. Tveden-Nyborg, P.; Johansen, L. K.; Raida, Z.; Villumsen, C. K.; Larsen, J. O.; Lykkesfeldt, J. (2009): Vitamin C deficiency in early postnatal life impairs spatial memory and reduces the number of hippocampal neurons in guinea pigs. Am. J. Clin. Nutr., 2009, 90, 540-546.
40. Musa-Veloso, K.; Card, J. W.; Wong, A. W.; Cooper, D. A. Influence of observational study design on the interpretation of cancer risk reduction by carotenoids. Nutr. Rev., 2009, 67, 527-545.
41. Ghosh, J.; Das, J.; Manna, P.; Sil, P. C. Taurine prevents arsenicinduced cardiac oxidative stress and apoptotic damage: role of NF-kappaB, p38 and JNK MAPK pathway. Toxicol. Appl. Pharmacol., 2009, 240, 73-87.
42. Ujhazy, E.; Dubovicky, M.; Ponechalova, V.; Navarova, J.; Brucknerova, I.; Snirc, V.; Mach, M. Prenatal developmental toxicity study of the pyridoindole antioxidant SMe1EC2 in rats. Neuroendocrinol. Lett., 2008, 29, 639-643.
43. Jessup, W.; Kritharides, L. Metabolism of oxidized LDL by macrophages. Curr. Opin. Lipidol., 2000, 11, 473-481.
44. Steinberg, D. The LDL modification hypothesis of atherogenesis: an update. J. Lipid. Res., 2009, 50, 376-381.
45. Persson, K.; Sauma, L.; Safholm, A.; Xu, L.; Li, W.; Yuan, X. M. LDL and U-oxidized LDL induce upregulation of iNOS and NO in unstimulated J774 macrophages and HUVEC. APMIS, 2009, 117, 1-9.
46. Vivier, E.; Tomasello E.; Baratin, M.; Walzer, T.; Ugolini, S. Functions of natural killer cells. Nat. Immunol., 2008, 9, 503-510. (Pubitemid 351560519)
47. Mackaness, G. B. The Immunological Basis of Acquired Cellular Resistance. J. Exp. Med., 1964, 120, 105-120.
48. Igietseme, J. U.; Perry, L. L.; Ananaba, G. A.; Uriri, I. M.; Ojior, O. O.; Kumar, S. N.; Caldwell, H. D. Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect. Immun., 1998, 66, 1282-1286. (Pubitemid 128471480)
49. Ehrt, S.; Schnappinger, D.; Bekiranov, S.; Drenkow, J.; Shi, S.; Gingeras, T. R.; Gaasterland, T.; Schoolnik, G.; Nathan, C. 2001. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med., 2001, 194, 1123-1140.
50. Shaughnessy, L. M.; Swanson, J. A. The role of the activated macrophage in clearing Listeria monocytogenes infection. Front. Biosci., 2007, 12, 2683-2692.
51. Mehta, A.; Brewington, R.; Chatterji, M.; Zoubine, M.; Kinasewitz, G. T.; Peer, G. T.; Chang, A. C.; Taylor, F. B.; Shnyra, A. Infectioninduced modulation of m1 and m2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis. Shock, 2004, 22, 423-430. (Pubitemid 39472566)
52. Bozza, F. A.; Salluh, J. I.; Japiassu, A. M.; Soares, M.; Assis, E. F.; Gomes, R. N.; Bozza, M. T.; Castro-Faria-Neto, H. C.; Bozza, P. T. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit. Care., 2007, 11, R49.
53. Lopez-Bojorquez, L. N.; Dehesa, A. Z.; Reyes-Teran, G. Molecular mechanisms involved in the pathogenesis of septic shock. Arch. Med. Res., 2004, 35, 465-479. (Pubitemid 41043616)
54. Anthony, R. M.; Rutitzky, L. I.; Urban, J. F.; Stadecker, M. J.; Gause, W. C. Protective immune mechanisms in helminth infection. Nat. Rev. Immunol., 2007, 7, 975-987. (Pubitemid 350166058)
55. Ostrand-Rosenberg, S.; Sinha, P. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol., 2009, 182, 4499-4506.
56. Ting, L. M.; Kim, A. C.; Cattamanchi, A.; Ernst, J. D. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J. Immunol., 1999, 163, 3898-3906. (Pubitemid 29450917)
57. Pauksens, K.; Fjaertoft, G.; Douhan-Hakansson, L.; Venge, P. Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia. Scand. J. Infect. Dis., 2008, 40, 326-337. (Pubitemid 351447996)
58. El Kasmi, K. C.; Qualls, J. E.; Pesce, J. T.; Smith, A. M.; Thompson, R. W.; Henao-Tamayo, M.; Basaraba, R. J.; Konig, T.; Schleicher, U.; Koo, M. S.; Kaplan, G.; Fitzgerald, K. A.; Tuomanen, E. I.; Orme, I. M.; Kanneganti, T. D.; Bogdan, C.; Wynn, T. A.; Murray, P. J. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol., 2008, 9, 1399-1406.
59. Sewell, D. L.; Reinke, E. K.; Hogan, L. H.; Sandor, M.; Fabry, Z. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol. Lett., 2002, 82, 101-110. (Pubitemid 34468041)
60. Khakoo, S. I.; Soni, P. N.; Savage, K.; Brown, D.; Dhillon, A. P.; Poulter, L. W.; Dusheiko, G. M. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity. Am. J. Pathol., 1997, 150, 963-970. (Pubitemid 27106168)
61. McGuinness, P. H.; Painter, D.; Davies, D.; McCaughan, G. W. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut, 2000, 46, 260-269. (Pubitemid 30305855)
62. Su, A. I.; Pezacki, J. P.; Wodicka, L.; Brideau, A. D.; Supekova, L.; Thimme, R.; Wieland, S.; Bukh, J.; Purcell, R. H.; Schultz, P. G.; Chisari, F. V. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. USA, 2002, 99, 15669-15674. (Pubitemid 35403989)
63. Fausther-Bovendo, H.; Sol-Foulon, N.; Candotti, D.; Agut, H.; Schwartz, O.; Debre, P.; Vieillard, V. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. AIDS, 2009, 23, 1077-1087.
64. Geijtenbeek, T. B. H. DC-SIGN, a dendritic cell-specific HIV-1 binding protein that enhances trans-infection of T cells. Cell, 2000, 100, 587-597.
65. Soumelis, V.; Scott, I.; Gheyas, F.; Bouhour, D.; Cozon, G.; Cotte, L.; Huang, L.; Levy, J. A.; Liu, Y. J. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood, 2001, 98, 906-912.
66. Gotch, F. M. Immunology of HIV. In: Gazzard BG. AIDS Care Handbook. London, Mediscript Ltd. 2002, 13-22.
67. Shimizu, N.; Tanaka, A.; Oue, A.; Mori, T.; Ohtsuki, T.; Apichartpiyakul, C.; Uchiumi, H.; Nojima, Y.; Hoshino, H. Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV. AIDS, 2009, 23, 761-769.
68. Fauci, A. S. HIV and AIDS: 20 years of science. Nat. Med., 2003, 9, 839-843. (Pubitemid 36889923)
69. Porcheray, F.; Samah, B.; Leone, C.; Dereuddre-Bosquet, N.; Gras, G. Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a proinflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. Vi ro l o g y, 2006, 349, 112-120. (Pubitemid 43732479)
70. Giri, M. S.; Nebozhyn, M.; Showe, L.; Montaner, L. J. Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. J. Leukoc. Biol., 2006, 80, 1031-1043. (Pubitemid 44646309)
71. Gordon, M. A., Gordon, S. B.; Musaya, L.; Yijlstra, E. E.; Molyneux, M. E.; Read, R. C. Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing. AIDS, 2007, 21, 2399-2408. (Pubitemid 350145171)
72. Levy, J. A. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS, 2009, 23, 147-160.
73. Bounou, S.; Leclerc, J. E.; Tremblay, M. J. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4 (+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J. Virol., 2002, 76, 1004-10014.
74. Arthos, J.; Cicala, C.; Martinelli, E.; MacIeod, K.; Van Ryk, D.; Wei, D.; Xiao, Z.; Veenstra, T. D.; Conrad, T. P.; Lempicki, R. A.; McLaughlin, S.; Pascuccio, M.; Gopaul, R.; NcNally, J.; Cruz, C. C.; Censoplano, N.; Chung, E.; Reitano, K. N.; Kottilil, S.; Goode, D. J.; Fauci, A. S. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat. Immunol., 2008, 9, 301-309. (Pubitemid 351267327)
75. Thanachai, H.; Makadzange, T.; Maenaka, K.; Kuroki, K.; Peng, Y.; Conlon, C.; Rowland-Jones, S.; Dong, T. Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells. AIDS, 2009, 23, 189-193.
76. Sylwester, A.; Murphy, S.; Shutt, D.; Soll, D. R. HIV-induced T cell syncytia are self-perpetuating and the primary cause of T cell death in culture. J. Immunol., 1997, 158, 3996-4007. (Pubitemid 127488761)
77. Day, C. L.; Kaufmann, D. E.; Kiepiela, P.; Brown, J. A.; Moodley, E. S.; Reddy, S.; Mackey, E. W.; Miller, J. D.; Leslie, A. J.; DePierres, C.; Mncube, Z.; Duraiswamy, J.; Zhu, B.; Eichbaum, Q.; Altfeld, M.; Wherry, E. J.; Coovadia, H. M.; Goulder, P. J.; Klenerman, P.; Ahmed, R.; Freeman, G. J.; Walker, B. D. PD-1 expression on HIV-specific T cell is associated with T-cell exhaustion and disease progression. Nature, 2006, 443, 350-354. (Pubitemid 44435155)
78. Quinn, T. C. HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS, 2008, 22, S7-S12.
79. Mahalingam, S.; Karupiah, G. Chemokines and chemokine receptors in infectious diseases. Immunol. Cell. Biol., 1999, 77, 469-475.
80. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol., 2004, 25, 677-686. (Pubitemid 39457982)
81. Mills, C. D.; Kincaid, K.; Alt, J. M.; Heilman, M. J.; Hill, A. M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol., 2000, 164, 6166-6173. (Pubitemid 30408793)
82. Badylak, S. F.; Valentin, J. E.; Ravindra, A. K.; McCabe, G. P.; Stewart-Akers, A. M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng. Part A., 2008, 14, 1835-42.
83. Brown, B. N.; Valentin, J. E.; Stewart-Akers, A. M.; McCabe, G. P.; Badylak, S. F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials, 2009, 30, 1482-1491.
84. Okuneva, V.; Zhvania, M.; Japaridze, N.; Gelazonia, L.; Lordkipanidze, T. Stress-system: corticotropin-releasing hormone and catecholamines (review). Georgian Med. News, 2009, 172, 65-69.
85. Webster-Marketon, J. I.; Glaser, R. Stress hormones and immune function. Cell. Immunol., 2008, 252, 16-26.
86. Azpiroz, A.; De Miguel, Z.; Fano, E.; Vegas, O. Relations between different coping strategies for social stress, tumor development and neuroendocrine and immune activity in male mice. Brain Behav. Immun., 2008, 22, 690-698. (Pubitemid 351794231)
87. Elenkov, I. J.; Wilder, R. L.; Chrousos, G. P.; Vizi, E. S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev., 2000, 52, 595-638.
88. Gosain, A.; Muthu, K.; Gamelli, R. L.; DiPietro, L. A. Norepinephrine suppresses wound macrophage phagocytic efficiency through alpha - and beta - adrenoreceptor dependent pathways. Surgery, 2007, 142, 170-179. (Pubitemid 47198679)
89. Azab, A. N.; Kaplanski, J. Vagotomy attenuates the effect of lipopolysaccharide on body temperature of rats in a dose-dependent manner. J. Endotoxin. Res., 2001, 7, 359-364. (Pubitemid 34048536)
90. Borovikova, L. V.; Ivanova, S.; Zhang, M.; Yang, H.; Botchkina, G. I.; Watkins, L. R.; Wang, H.; Abumrad, N.; Eaton, J. W.; Tracey, K. J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 2000, 405, 458-462. (Pubitemid 30367422)
91. Kaufer, D.; Friedman, A.; Seldman, S.; Soreq, H. Acute stress facilitates long - lasting changes in cholinergic gene expression. Nature, 1998, 393, 373-377. (Pubitemid 28269711)
92. Tracey, K. J. The inflammatory reflex. Nature, 2002, 420, 853-859. (Pubitemid 36019638)
93. Tracey, K. J. Reflex control of immunity. Natur. Rev. Immunol., 2009, 9, 418-428.
94. Wang, H.; Yu, M.; Ochani, M.; Amella, C. A.; Tanovic, M.; Susaria, S.; Li, J. H.; Wang, H.; Yang, H.; Ulloa, L.; Al-Abed, Y.; Czura, C. J.; Tracey, K. J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature, 2003, 421, 384-388. (Pubitemid 36157937)
95. Parrish, W. R.; Rosas-Ballina, M.; Gallowitsch-Puerta, M.; Ochani, M.; Ochani, K.; Yang, L. H.; Hudson, L.; Lin, X.; Patel, N.; Johnson, S. N.; Chavan, S.; Goldstein, R. S.; Czura, C. J.; Miller, E. J.; Al-Abed, Y.; Tracey, K. J.; Pavlov, V. A. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptormediated signaling. Mol. Med., 2008, 14, 567-574.
96. Rosas-Ballina, M.; Tracey, K. J. Cholinergic control of inflammation. J. Intern. Med., 2009, 265, 663-679.
97. Johnston, G. R.; Webster, N. R. Cytokines and the immunomodulatory function of the vagus nerve. Br. J. Anaesth., 2009, 102, 453-462.
98. Wilund, K. R.; Rosenblat, M.; Chung, H. R.; Volkova, N.; Kaplan, M.; Woods, J.; Aviram, M. Macrophages from alpha 7 nicotinic acetylcholine receptor knockout mice demonstrate increased cholesterol accumulation and decreased cellular paraoxonase expression: a possible link between the nervous system and atherosclerosis development. Biochem. Biophys. Res. Commun., 2009, 390, 148-154.
99. Ishii, M.; Kurachi, Y. Muscarinic acetylcholine receptors. Curr. Pharm. Des., 2006, 12, 3573-3581. (Pubitemid 44509627)
100. Albuquerque, E. X.; Pereira, E. F. R.; Alkondon, M.; Rogers, S. W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev., 2009, 89, 73-120.
101. Portugal, G. S.; Gould, T. J. Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Behav. Brain Res., 2008, 193, 1-16.
102. Resende, R. R.; Adhikari A. Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation. Cell Commun. Signal., 2009, 7, 20.
103. Morley, B. J.; Happe H. K. Cholinergic receptors: dual roles in transduction and plasticity. Hear. Res., 2000, 147, 104-112. (Pubitemid 30658058)
104. Decker, M. W.; Rueter, L. E.; Bitner, R. S. Nicotinic acetylcholine receptor agonists: a potential new class of analgesics. Curr. Top. Med. Chem., 2004, 4, 369-384. (Pubitemid 38842575)
105. Lindstrom, J. M. Acetylcholine receptors and myasthenia. Muscle Nerve, 2000, 23, 453-477. (Pubitemid 30164770)
106. Tsetlin, V.; Utkin, Y.; Kasheverov, I. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors. Biochem. Pharmacol, 2009, 78, 720-731.
107. Gorfe, A. A.; Chang, C. A.; Ivanov, I.; McCammon, J. A. Dynamics of the acetylcholinesterase tetramer. Biophys. J., 2008, 94, 1144-1154.
108. Pohanka, M.; Novotny, L.; Misik, J.; Kuca, K.; Zdarova-Karasova, J.; Hrabinova, M. Evaluation of cholinesterase activities during in vivo intoxication using an electrochemical sensor strip-correlation with intoxication symptoms. Sensors, 2009, 9, 3627-3634.
109. Pohanka, M.; Musilek, K.; Kuca, K. Progress of biosensors based on cholinesterase inhibition. Curr. Med. Chem., 2009, 16, 1790-1798.
110. Balali-Mood, M.; Balali-Mood, K. Neurotoxic disorders of organophosphorus compounds and their managements. Arch. Iran. Med., 2008, 11, 65-89. (Pubitemid 351233553)
111. Pohanka, M.; Kuca, K.; Jun, D. Aflatoxin assay using an amperometric sensor strip and acetylcholinesterase as recognition element. Sens. Lett., 2008, 6, 450-453.
112. Brenner, T.; Nizri, E.; Irony-Tur-Sinai, M.; Hamra-Amitay, Y.; Wirguin, I. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation. J. Neuroimmunol., 2008, 201, 121127.
113. Pohanka, M.; Karasova, J. Z.; Musilek, K.; Kuca, K.; Jung, Y. S.; Kassa, J. Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators. J. Enzyme Inhib. Med. Chem., 2010, DOI:10.3109/14756361003733613.
114. Chao, W. W.; Kuo, Y. H.; Hsieh, S. L.; Lin, B. F. Inhibitory effects of ethyl acetate extract of Andrographis paniculata on NF-kB transactivation activity and LPS-induced acute inflammation in mice. Evid. Based. Complement. Alternat. Med, 2009, DOI:10.1093/ecam/nep120.
115. Lin, J.; Ziring, D.; Desai, S.; Kim, S.; Wong, M.; Korin, Y.; Braun, J.; Reed, E.; Gjertson, D.; Singh, R. R. TNFα blockade in human diseases: an overview of efficacy and safety. Clin. Immunol, 2008, 126, 13-30. (Pubitemid 350266448)
116. Pache, I.; Rogler, G.; Felley, C. TNF-α blockers in inflammatory bowel diseases: practical consensus recommendations and a user's guide. Swiss Med. Wkly, 2009, 139, 278-287.
117. Rodrigues, E. B; Farah, M. E.; Maia, M.; Penha, F. M.; Regatieri; C.; Melo, G. B.; Pinheiro, M. M.; Zanetti, C. R. Therapeutic monoclonal antibodies in ophthalmology. Prog. Retin. Eye Res., 2009, 28, 117-144.
118. Bernik, T. R.; Friedmsan, S. G.; Ochani, M.; DiRaimo, R.; Ulloa, L.; Yang, H.; Sudan, S.; Czura, C. J.; Ivanova, S. M.; Tracey, K. J. Pharmacological stimulation of the cholinergic anti-inflammatory pathway. J. Exp. Med., 2002, 195, 781-788. (Pubitemid 34259722)
119. Bianchi, M.; Bloom, O.; Sherry, B.; Chesney, J.; Cohen, P.; Ulrich, P.; Raabe, T.; Bukrinsky, M.; Cerami, A.; Tracey, K. J. Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J. Exp. Med., 1996, 83, 927-936. (Pubitemid 26114796)
120. Van Maanen, M. A.; Lebre, M. C.; van der Poll, T.; LaRosa, G. J.; Elbaum, D.; Vervoordeldonk, M. J.; Tak, P. P. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis. Rheum., 2009, 60, 114-122.
121. Mabley, J. G.; Pacher, P.; Szabo, C. Activation of the cholinergic anti-inflammatory pathway reduces ricin-induced mortality and organ failure in mice. Mol. Med, 2009, 15, 166-172.
122. Kawahara, R.; Yasuda, M.; Hashimura, H.; Amagase, K.; Kato, S.; Takeuchi, K. Activation of α7 nicotinic acetylcholine receptors ameliorates indomethacin-induced small intestinal ulceration in mice. Eur. J. Pharmacol, 2010, [Epub ahead of print].
123. Buccafusco, J. J.; Beach, J. W.; Terry, A. V. Desensitization of nicotinic acetylcholine receptors as a strategy for drug development. J. Pharmacol. Exp. Ther., 2009, 328, 364-370.
124. Liu, X.; Testa, B.; Fahr, A. Lipophilicity and its relationship with passive drug permeation. Pharm. Res., 2010, [Epub ahead of print].
125. Tsuji, A. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx., 2005, 2, 54-62. (Pubitemid 40128026)
126. Ohtsuki, S.; Terasaki, T. Contribution of carrier-mediated transport system to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm. Res., 2007, 24, 1745-1758. (Pubitemid 47206624)
127. Pavlov, V. A.; Wang, H.; Czura, C. J.; Friedman, S. G.; Tracey, K. J. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med., 2003, 9, 125-134. (Pubitemid 37310949)
128. Tracey, K. J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest., 2007, 117, 289-296. (Pubitemid 46203953)
129. Pohanka, M.; Pejchal, J.; Horackova, S.; Kuca, K.; Bandouchova, H.; D'Amkova, V.; Pikula, J. Modulation of ionising radiation generated oxidative stress by HI-(asoxime) in a laboratory rat model. Neuroendocrinol. Lett., 2011, In press.